Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06557148
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-13
Brief Title:
A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer
Sponsor:
None
Organization:
None
Study Overview
Official Title:
18F-Fluoroestradiol FES Positron Emission Tomography for the Detection and Treatment Response Monitoring in Patients With Metastatic Lobular Breast Carcinoma
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study to compare two types of cancer imaging scans to see which is better at detecting and monitoring metastatic ILC This study will compare PETCT positron emission tomographycomputed tomography scans using the radiotracer fluorine 18 18F-fluoroestradiol FES with a standard imaging approach for detecting and monitoring ILC PETCT scans using the radiotracer 18F-fluorodeoxyglucose FDG These scans will be referred to as FES PETCT scans and FDG PETCT scans
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None